It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt. An FDA advisory committee ...

Three weeks after taking over as CEO of Lexicon Pharmaceuticals back in 2024, Michael Exton suggested the company close its commercial operations. He knew the Texas-based biopharma needed to change ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Novo Nordisk began a Phase 1 study of an oral obesity-drug candidate it agreed to license from Lexicon Pharmaceuticals last year. The study is investigating the safety and tolerability of the drug, ...

The last time I spoke about Lexicon Pharmaceuticals, Inc. (LXRX) it was with respect to a Seeking Alpha article entitled "Advisory Panel Votes In Split Fashion For Lexicon's Drug: What does That Mean ...

Lexicon Inc., a Little Rock-based construction management and steel fabrication company, said Thursday it has become a private, employee-owned company. Lexicon said the decision comes after a ...

Dezeen Showroom: Italian brand Fiandre aimed to create a "vocabulary of surfaces" with the Lexicon tile collection, featuring eight high-tech stone- and marble-inspired designs. Both atmospheric, ...

A town's major shopping centre has reportedly been bought by an investment firm for about £150m. US-based Realty Income bought The Lexicon in Bracknell from previous owners Schroder Capital UK Real ...

Lexicon Pharmaceuticals is positioned for a potential turnaround with three key drug programs and recent partnerships, despite a challenging history. LXRX's sotagliflozin faces uncertain FDA approval ...

Some Dún Laoghaire doors were slammed in canvassing politicians’ faces in advance of the 2014 local elections if they admitted they supported the then yet to open library, according to local ...